KRTX
Vanguard Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,224,786
| Closed | -$1.02B | – | 4503 |
|
|
2023
Q4 | $1.02B | Buy |
3,224,786
+21,201
| +0.7% | +$6.71M | 0.02% | 618 |
|
|
2023
Q3 | $542M | Buy |
3,203,585
+105,686
| +3% | +$17.9M | 0.01% | 859 |
|
|
2023
Q2 | $672M | Buy |
3,097,899
+78,353
| +3% | +$17M | 0.02% | 758 |
|
|
2023
Q1 | $548M | Buy |
3,019,546
+266,003
| +10% | +$48.3M | 0.01% | 848 |
|
|
2022
Q4 | $541M | Buy |
2,753,543
+131,958
| +5% | +$25.9M | 0.01% | 835 |
|
|
2022
Q3 | $590M | Buy |
2,621,585
+448,871
| +21% | +$101M | 0.02% | 740 |
|
|
2022
Q2 | $275M | Buy |
2,172,714
+51,562
| +2% | +$6.52M | 0.01% | 1235 |
|
|
2022
Q1 | $269M | Buy |
2,121,152
+36,816
| +2% | +$4.67M | 0.01% | 1354 |
|
|
2021
Q4 | $273M | Buy |
2,084,336
+18,945
| +0.9% | +$2.48M | 0.01% | 1411 |
|
|
2021
Q3 | $253M | Buy |
2,065,391
+49,641
| +2% | +$6.07M | 0.01% | 1452 |
|
|
2021
Q2 | $230M | Buy |
2,015,750
+106,547
| +6% | +$12.1M | 0.01% | 1548 |
|
|
2021
Q1 | $230M | Buy |
1,909,203
+690,602
| +57% | +$83M | 0.01% | 1514 |
|
|
2020
Q4 | $124M | Buy |
1,218,601
+25,847
| +2% | +$2.63M | ﹤0.01% | 1729 |
|
|
2020
Q3 | $92.2M | Buy |
1,192,754
+102,202
| +9% | +$7.9M | ﹤0.01% | 1725 |
|
|
2020
Q2 | $122M | Buy |
1,090,552
+587,085
| +117% | +$65.4M | ﹤0.01% | 1571 |
|
|
2020
Q1 | $36.3M | Buy |
503,467
+73,513
| +17% | +$5.29M | ﹤0.01% | 2012 |
|
|
2019
Q4 | $32.4M | Buy |
429,954
+208,074
| +94% | +$15.7M | ﹤0.01% | 2310 |
|
|
2019
Q3 | $3.62M | Buy |
221,880
+157,268
| +243% | +$2.57M | ﹤0.01% | 3253 |
|
|
2019
Q2 | $1.29M | Buy |
+64,612
| New | +$1.29M | ﹤0.01% | 3596 |
|